Missouri is the United States’ new COVID-19 hot spot as the Delta variant spreads rapidly throughout the state. According to the US Centers for Disease Control and Prevention, the “show-me” state has the highest rate of new infections. With…

A Brazilian study on the use of proxalutamide, a new drug indicated for prostate cancer, provided unexpected benefits for hospitalized patients with COVID-19. Results showed that 81% of patients with COVID-19 who received proxalutamide for…

New research from the National Institutes of Health has found that the immunity acquired from COVID-19 vaccination seems to be more adept at creating antibodies to a wide spectrum of SARS-CoV-2 variants than the immunity gained…

Individuals who experience migraine headaches may be at increased risk of contracting COVID-19 or suffer more severe symptoms, according to research presented at the annual meeting of the American Headache Society. Data from more than 170…

More than 20 million young people in the United States have been vaccinated against COVID-19, and the US Centers for Disease Control and Prevention has found 300 cases of myocarditis or pericarditis among this population following…

Delta, the newest and most virulent COVID-19 variant that has ravaged India, is quickly spreading around the globe. Unfortunately, this variant causes twice as many hospitalizations as previous iterations of the novel coronavirus, according…

The United States Department of Health and Human Services is spending more than $3 billion to develop anti-viral pills to treat COVID-19. The significant financial commitment will support clinical trials of three potentially viable…

A white paper titled “A Detailed Study of Patients With Long-Haul COVID-19” has found that 23% of patients who recovered from COVID-19 still face lingering health problems. The study investigated health insurance claims of more than 2…

The United States Department of Health and Human Services (HHS) has extended the deadline for using payments provided via the Provider Relief Fund. The initial deadline to use the funds distributed to healthcare providers in order to…

Researchers from the University of Bristol found that infants mount a stronger immune response to COVID-19 than many adults. The results, published in Cell Reports Medicine, found that infants younger than 3 months of age generated high…